Global Peripheral Intervention Drug-Eluting Devices Sales Market Report 2021

1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Peripheral Intervention Drug-Eluting Devices Product Scope
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2016 & 2021 & 2027)
1.2.2 Plain Old Balloon Angioplasty (POBA)
1.2.3 Percutaneous Transluminal Angioplasty (PTA)
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Drug-Eluting Balloons
1.3.3 Drug-Eluting Stents
1.4 Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts (2016-2027)
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Peripheral Intervention Drug-Eluting Devices Price Trends (2016-2027)

2 Peripheral Intervention Drug-Eluting Devices Estimates and Forecasts by Region
2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2021)
2.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region (2016-2021)
2.3 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.2 Europe Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.3 China Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.4 Japan Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
2.4.6 India Peripheral Intervention Drug-Eluting Devices Estimates and Projections (2016-2027)
3 Global Peripheral Intervention Drug-Eluting Devices Competition Landscape by Players
3.1 Global Top Peripheral Intervention Drug-Eluting Devices Players by Sales (2016-2021)
3.2 Global Top Peripheral Intervention Drug-Eluting Devices Players by Revenue (2016-2021)
3.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2020)
3.4 Global Peripheral Intervention Drug-Eluting Devices Average Price by Company (2016-2021)
3.5 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Type (2016-2021)
4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2016-2021)
4.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2016-2021)
4.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2022-2027)
4.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2022-2027)
5 Global Peripheral Intervention Drug-Eluting Devices Market Size by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Review by Application (2016-2021)
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2016-2021)
5.1.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2016-2021)
5.2 Global Peripheral Intervention Drug-Eluting Devices Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Application (2022-2027)
5.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Application (2022-2027)

6 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
6.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Company
6.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
6.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
6.2 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
6.2.1 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
6.2.2 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
6.3 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
6.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
6.3.2 North America Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

7 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
7.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Company
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
7.2.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
7.2.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
7.3 Europe Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
8.1 China Peripheral Intervention Drug-Eluting Devices Sales by Company
8.1.1 China Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
8.1.2 China Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
8.2 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
8.2.1 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
8.2.2 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
8.3 China Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
9.1 Japan Peripheral Intervention Drug-Eluting Devices Sales by Company
9.1.1 Japan Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
9.1.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
9.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
9.2.1 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
9.2.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
9.3 Japan Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
10.1 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Company
10.1.1 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
10.1.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
10.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
10.2.1 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Peripheral Intervention Drug-Eluting Devices Market Facts & Figures
11.1 India Peripheral Intervention Drug-Eluting Devices Sales by Company
11.1.1 India Peripheral Intervention Drug-Eluting Devices Sales by Company (2016-2021)
11.1.2 India Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021)
11.2 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type
11.2.1 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2016-2021)
11.2.2 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Type (2022-2027)
11.3 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application
11.3.1 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2016-2021)
11.3.2 India Peripheral Intervention Drug-Eluting Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Peripheral Intervention Drug-Eluting Devices Business
12.1 Medtronic plc
12.1.1 Medtronic plc Corporation Information
12.1.2 Medtronic plc Business Overview
12.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Products Offered
12.1.5 Medtronic plc Recent Development
12.2 Boston Scientific Corporation
12.2.1 Boston Scientific Corporation Corporation Information
12.2.2 Boston Scientific Corporation Business Overview
12.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.2.5 Boston Scientific Corporation Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Corporation Information
12.3.2 Abbott Laboratories Business Overview
12.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Products Offered
12.3.5 Abbott Laboratories Recent Development
12.4 Cardinal Health
12.4.1 Cardinal Health Corporation Information
12.4.2 Cardinal Health Business Overview
12.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Products Offered
12.4.5 Cardinal Health Recent Development
12.5 B. Braun Melsungen AG
12.5.1 B. Braun Melsungen AG Corporation Information
12.5.2 B. Braun Melsungen AG Business Overview
12.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Products Offered
12.5.5 B. Braun Melsungen AG Recent Development
12.6 Biosensors International Group Ltd.
12.6.1 Biosensors International Group Ltd. Corporation Information
12.6.2 Biosensors International Group Ltd. Business Overview
12.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Products Offered
12.6.5 Biosensors International Group Ltd. Recent Development
12.7 C.R. Bard, Inc.
12.7.1 C.R. Bard, Inc. Corporation Information
12.7.2 C.R. Bard, Inc. Business Overview
12.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.7.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Products Offered
12.7.5 C.R. Bard, Inc. Recent Development
12.8 Abbott
12.8.1 Abbott Corporation Information
12.8.2 Abbott Business Overview
12.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Products Offered
12.8.5 Abbott Recent Development
12.9 The Lubrizol Corporation
12.9.1 The Lubrizol Corporation Corporation Information
12.9.2 The Lubrizol Corporation Business Overview
12.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.9.5 The Lubrizol Corporation Recent Development
12.10 Terumo Corporation
12.10.1 Terumo Corporation Corporation Information
12.10.2 Terumo Corporation Business Overview
12.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Products Offered
12.10.5 Terumo Corporation Recent Development

13 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
13.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
13.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peripheral Intervention Drug-Eluting Devices Distributors List
14.3 Peripheral Intervention Drug-Eluting Devices Customers

15 Market Dynamics
15.1 Peripheral Intervention Drug-Eluting Devices Market Trends
15.2 Peripheral Intervention Drug-Eluting Devices Drivers
15.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
15.4 Peripheral Intervention Drug-Eluting Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Peripheral Intervention Drug-Eluting Devices Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Peripheral Intervention Drug-Eluting Devices Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Region (2016-2021)
Table 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Region (2016-2021)
Table 6. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Region (2016-2021)
Table 8. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Peripheral Intervention Drug-Eluting Devices Revenue Share Forecast by Region (2022-2027)
Table 12. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Company (2016-2021)
Table 14. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Company (2016-2021)
Table 16. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2020)
Table 17. Global Peripheral Intervention Drug-Eluting Devices Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites and Area Served
Table 19. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Type (2016-2021)
Table 22. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2016-2021)
Table 23. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2016-2021)
Table 25. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2022-2027)
Table 26. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2022-2027)
Table 28. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Type (2022-2027)
Table 29. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2016-2021)
Table 30. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2016-2021)
Table 31. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2016-2021)
Table 33. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Application (2022-2027)
Table 34. Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2022-2027)
Table 35. Global Peripheral Intervention Drug-Eluting Devices Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2022-2027)
Table 37. Global Peripheral Intervention Drug-Eluting Devices Price (USD/Unit) by Application (2022-2027)
Table 38. North America Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 39. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 40. North America Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 42. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 43. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 44. North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 45. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 46. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 47. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 48. North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 49. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 50. Europe Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 51. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 52. Europe Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 54. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 55. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 56. Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 57. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 58. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 59. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 60. Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 61. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 62. China Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 63. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 64. China Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 66. China Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 67. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 68. China Peripheral Intervention Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 69. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 70. China Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 71. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 72. China Peripheral Intervention Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 73. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 74. Japan Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 75. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 76. Japan Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 78. Japan Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 79. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 80. Japan Peripheral Intervention Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 81. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 82. Japan Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 83. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 84. Japan Peripheral Intervention Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 85. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 98. India Peripheral Intervention Drug-Eluting Devices Sales (K Units) by Company (2016-2021)
Table 99. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Company (2016-2021)
Table 100. India Peripheral Intervention Drug-Eluting Devices Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Company (2016-2021)
Table 102. India Peripheral Intervention Drug-Eluting Devices Sales by Type (2016-2021) & (K Units)
Table 103. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2016-2021)
Table 104. India Peripheral Intervention Drug-Eluting Devices Sales by Type (2022-2027) & (K Units)
Table 105. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2022-2027)
Table 106. India Peripheral Intervention Drug-Eluting Devices Sales by Application (2016-2021) & (K Units)
Table 107. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2016-2021)
Table 108. India Peripheral Intervention Drug-Eluting Devices Sales by Application (2022-2027) & (K Units)
Table 109. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2022-2027)
Table 110. Medtronic plc Corporation Information
Table 111. Medtronic plc Description and Business Overview
Table 112. Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Medtronic plc Peripheral Intervention Drug-Eluting Devices Product
Table 114. Medtronic plc Recent Development
Table 115. Boston Scientific Corporation Corporation Information
Table 116. Boston Scientific Corporation Description and Business Overview
Table 117. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 119. Boston Scientific Corporation Recent Development
Table 120. Abbott Laboratories Corporation Information
Table 121. Abbott Laboratories Description and Business Overview
Table 122. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product
Table 124. Abbott Laboratories Recent Development
Table 125. Cardinal Health Corporation Information
Table 126. Cardinal Health Description and Business Overview
Table 127. Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Cardinal Health Peripheral Intervention Drug-Eluting Devices Product
Table 129. Cardinal Health Recent Development
Table 130. B. Braun Melsungen AG Corporation Information
Table 131. B. Braun Melsungen AG Description and Business Overview
Table 132. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product
Table 134. B. Braun Melsungen AG Recent Development
Table 135. Biosensors International Group Ltd. Corporation Information
Table 136. Biosensors International Group Ltd. Description and Business Overview
Table 137. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product
Table 139. Biosensors International Group Ltd. Recent Development
Table 140. C.R. Bard, Inc. Corporation Information
Table 141. C.R. Bard, Inc. Description and Business Overview
Table 142. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product
Table 144. C.R. Bard, Inc. Recent Development
Table 145. Abbott Corporation Information
Table 146. Abbott Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Abbott Description and Business Overview
Table 148. Abbott Peripheral Intervention Drug-Eluting Devices Product
Table 149. Abbott Recent Development
Table 150. The Lubrizol Corporation Corporation Information
Table 151. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. The Lubrizol Corporation Description and Business Overview
Table 153. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 154. The Lubrizol Corporation Recent Development
Table 155. Terumo Corporation Corporation Information
Table 156. Terumo Corporation Description and Business Overview
Table 157. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product
Table 159. Terumo Corporation Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Peripheral Intervention Drug-Eluting Devices Distributors List
Table 163. Peripheral Intervention Drug-Eluting Devices Customers List
Table 164. Peripheral Intervention Drug-Eluting Devices Market Trends
Table 165. Peripheral Intervention Drug-Eluting Devices Market Drivers
Table 166. Peripheral Intervention Drug-Eluting Devices Market Challenges
Table 167. Peripheral Intervention Drug-Eluting Devices Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture
Figure 2. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2021 & 2027
Figure 6. Drug-Eluting Balloons Examples
Figure 7. Drug-Eluting Stents Examples
Figure 8. Global Peripheral Intervention Drug-Eluting Devices Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Peripheral Intervention Drug-Eluting Devices Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Peripheral Intervention Drug-Eluting Devices Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Peripheral Intervention Drug-Eluting Devices Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Peripheral Intervention Drug-Eluting Devices Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Peripheral Intervention Drug-Eluting Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue in Peripheral Intervention Drug-Eluting Devices: 2016 & 2020
Figure 27. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2016-2021)
Figure 29. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Application (2016-2021)
Figure 31. Global Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 33. North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 34. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 35. Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 36. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 37. China Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 38. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 39. Japan Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 40. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 41. Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 42. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 43. India Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Peripheral Intervention Drug-Eluting Devices
Figure 46. Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
Figure 47. Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.